Epidemiology of pre invasive and invasive lesions of the cervix at tertiary health centre in Punjab

Authors

  • Garima Bhardwaj Department of Obstetrics and Gynaecology, Government Medical College, Amritsar, Punjab, India
  • Amritpal Kaur Department of Obstetrics and Gynaecology, Government Medical College, Amritsar, Punjab, India
  • Permeet Kaur Bagga Department of Pathology, Government Medical College, Amritsar, Punjab, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20210963

Keywords:

Human papilloma virus, NILM, LSIL, HSIL, CIN, SCC

Abstract

Background: Cervical cancer is the fourth most frequent cancer in women globally, next to breast, colorectal and lung cancer and it is also the fourth most common cause of cancer death in women. According to the Indian council of medical research (ICMR), in India one woman dies of cervical cancer every 9 minutes. This study used PAP smear and histopathology to find out about the epidemiology of pre invasive and invasive lesions of the cervix at tertiary health centre in Punjab and their correlation with various social and demographic features.

Methods: This prospective clinical study was carried out in the Department of Obstetrics and Gynaecology in Amritsar Medical College from May 2018 to April 2020, after taking approval from the Institutional Ethical Committee. The study selected 500 women randomly among the patients attending the Gynaecology OPD who met the inclusion criteria. Detailed history and PAP smear was taken at first visit followed by cervical biopsy amongst women with abnormal cytology report or with frank lesions of cervix.

Results: Out of 500 women included in the study, majority of women (82.5%) were Negative for intraepithelial lesion or malignancy (NILM), 4% women had Atypical squamous cells of undetermined significance (ASCUS), 6.1% had low grade squamous intraepithelial lesion (LSIL) and 16 (3.2%) had High grade squamous intraepithelial lesion (HSIL). Amongst the histopathology reporting 15.62% patients had cervical intraepithelial neoplasia 1 (CIN I), 6.25% patients had cervical intraepithelial neoplasia II (CIN II), 3.12% patients had cervical intraepithelial neoplasia III (CIN III), 6.3% patients had squamous cell carcinoma and 3.1% patient had adenocarcinoma of cervix. Age, low level of education, poor socioeconomic status, early marriage and multiparity are the risk factors found to be associated with pre invasive and invasive lesions of the cervix. (p<0.001).

Conclusions: Though infection with human papilloma virus (HPV) is essential for the development of the disease, there are other high-risk factors like age, poor education, low socioeconomic status, early age at marriage and high parity which are significantly associated with the occurrence of the disease. Therefore, our primary and secondary preventive measures must include the women who come under these high-risk categories. 

Author Biographies

Garima Bhardwaj, Department of Obstetrics and Gynaecology, Government Medical College, Amritsar, Punjab, India

Obstetrics and gynaecology

Post graduate student

Amritpal Kaur, Department of Obstetrics and Gynaecology, Government Medical College, Amritsar, Punjab, India

Professor

Department of Obstetrics and gynaecology

Permeet Kaur Bagga, Department of Pathology, Government Medical College, Amritsar, Punjab, India

Associate professor

Department of pathology

References

Globocan 2018: India Factsheet. India against Cancer; 2018. Available at: http://cancerindia.org.in/globocan-2018-india-factsheet/. Accessed on 01 April 2020.

National Institute of Cancer Prevention & Research. National Cancer Registry Programme of the Indian Council of Medical Research.Over 17 lakh new cancer cases in India by 2020: ICMR. Available at: https://www.ncdirindia.org/Area_Cancer.aspx. Accessed on 20 April 2020.

World Health Organisation. International agency for research on cancer. Press release 5th December 2019 New study provides baseline to measure impact of cervical cancer elimination objectives

HPV Information Centre - Human papilloma virus and related disease, summary report 17 June 2019.Available at: www.hpvcentre.net. Accessed on 20 April 2020.

Bray F, Ferlay j, Soerjomataram I, siegelRl, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCON estimates odf incidence and mortality worldwide for 36 cancers in 185 countrie. CA Cancer J Clin. 2018;68:394-424.

American Cancer Society. Key Statistics for Cervical Cancer.Last Revised: January 8, 2020. Available at https://www.cancer.org/cancer/cervicalcancer/about/key-statistics.html. Accessed on 20 April 2020.

Arbyn M, Weiderpass E, Bruni L, de Sanjosé S, Saraiya M, Ferlay J, Bray F. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Heal. 2020;8(2):e191-203.

Papillomaviruses H. IARC monographs on the evaluation of carcinogenic risks to humans. Lyon, France: IARC. 2011. Available at: https://monographs.iarc.fr/wpcontent/uploads/2018/06/mono90.pdf. Accessed on 20 April 2020.

Sreedevi A, Javed R, Dinesh A. Epidemiology of cervical cancer with special focus on India. Int J Womens Heal. 2015;7:405-14.

Mamulwar M, Godbole S, Bembalkar S, Kamble P, Dulhani N, Yadav R, et al. Differing HIV vulnerability among female sex workers in a high HIV burden Indian state. PLoS One. 2018;13(2):e0192130.

Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55(4):244-65.

Louie KS, De Sanjose S, Diaz M, Castellsague X, Herrero R, Meijer CJ, Shah K, Franceschi S, Muñoz N, Bosch FX. Early age at first sexual intercourse and early pregnancy are risk factors for cervical cancer in developing countries. Brit J Canc. 2009;100(7):1191-7.

Ursin G, Peters RK, Monroe K, Pike MC, Henderson BE. Oral contraceptive use and adenocarcinoma of cervix. Lancet. 1994;344(8934):1390-4.

Schiffman M. Cancer Epidemiology and Prevention. In: Schottenfeld D, FraumeniJr JF, editors, 3rd Edn. Oxford University Press; 2006.

McGraw SL, Ferrante JM. Update on prevention and screening of cervical cancer. World J Clinic Oncol. 2014;5(4):744.

Fahey MT, Irwig L, Macaskill P. Meta-analysis of Pap test accuracy. Am J Epidemiol. 1995;141(7):680-9.

Kashyap N, Krishnan N, Kaur S, Ghai S. Risk factors of cervical Cancer: a case-control study. Asia-Pacific J Oncol Nurs. 2019;6(3):308.

Bhatnagar K, Baghel K. Epidemiology of patients with bad cervix attending gynaecology OPD of a tertiary care centre in western Uttar Pradesh, India. Int J Reprod Contracept Obstet Gynecol. 2017;6:791-6.

El-Moselhy EA, Borg HM, Atlam SA. Cervical Cancer: sociodemographic and clinical risk factors among adult Egyptian females. Adv Oncol Res Treat. 2016;1(1):106.

Khalaf MK, Rasheed FA, Hussain SA. Association between early marriage and other sociomedical characteristics with the cervical pap smear results in Iraqi women. Advan Sex Medic. 2015;5(04):73.

Gupta K, Malik NP, Sharma VK, Verma N, Gupta A. Prevalence of cervical dysplasia in western Uttar Pradesh. J Cytol Acad Cytolog. 2013;30 (4):257.

Mhaske M, Jawadekar SJ, Saundale SG. Study of association of some risk factors & cervical dysplasia/cancer among rural women. Nat J Comm Med. 2011;2(2):209-12.

Misra JS, Srivastava S, Singh U, Srivastava AN. Risk-factors and strategies for control of carcinoma cervix in India: Hospital based cytological screening experience of 35 years. Ind J Canc. 2009;46(2):155.

Downloads

Published

2021-03-24

Issue

Section

Original Research Articles